整体葡萄糖颗粒通过Dectin-1激活增强免疫调节,结合TIGIT检查点阻断通过Dectin-1激活
Shuyan He1, Xinru Xiao2, Faisal Raza3
1Department of Tumor Center, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, 214400, Jiangsu, China.
International journal of biological macromolecules
|December 21, 2025
概括
将整个葡萄糖颗粒 (WGP) 与TIGIT检查点封锁相结合,可以增强抗瘤免疫力. 这种组合疗法有效地减少了瘤负担,并通过重编程髓状细胞和激活免疫反应来改善生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 检查点阻断抗体TIGIT (具有Ig和ITIM域的T细胞免疫受体) 是一种新兴的癌症免疫疗法.
- 单独的TIGIT阻塞的有效性通常在对抗瘤方面是有限的.
研究的目的:
- 为了评估结合整个葡萄糖颗粒 (WGP),一个免疫辅助剂,与抗TIGIT抗体治疗的疗效.
- 在临床前癌症模型中研究这种联合治疗的潜在免疫机制.
主要方法:
- 使用WGP和抗TIGIT抗体的联合治疗在LLC肺癌和4T1乳腺癌模型中进行了测试.
- 免疫分析包括分析内免疫细胞 (T细胞,NK细胞,巨细胞,MDSCs,Tregs),细胞因子水平和血清免疫球蛋白.
- 评估了Dectin-1信号通路 (Syk/NF-κB) 和MDSC细胞亡. 使用Dectin-1淘汰赛小鼠来确认WGP的机制.
主要成果:
- 与单一治疗相比,组合疗法显著降低了瘤负担和延长了生存时间.
- 观察到内增强的CD8+ T和NK细胞,M1-类巨细胞偏振,以及减少的MDSC和Tregs.
- 证实WGP的辅助作用依赖于Dectin-1,涉及髓状细胞重编程和先天适应性免疫激活.
结论:
- 整体葡萄糖颗粒 (WGP) 作为一种强大的辅助剂,通过Dectin-1-介导的机制增加TIGIT阻断的有效性.
- 这种组合疗法通过协调先天性和适应性免疫反应,代表了癌症治疗的有希望的策略.
- 基于β-葡萄糖的先天性免疫原始化是一种合理的方法来增强TIGIT和其他T细胞导向检查点抑制剂.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


